DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53

EMBO Journal

Volumn 21, Issue 12, 2002, Pages 3000-3008

  Woo, Richard A ^a   Jack, Melissa T ^a   Xu, Yang ^a   Burma, Sandeep ^a   Chen, David J ^a   Lee, Patrick W K ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Apoptosis; DNA damage; DNA dependent protein kinase; P53; Ser15

Indexed keywords

CYCLOHEXIMIDE; DNA DEPENDENT PROTEIN KINASE; DOUBLE STRANDED DNA; LIPOCORTIN 5; PROTEIN P53;

AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; DNA PROTEIN COMPLEX; DNA STRAND BREAKAGE; FIBROBLAST; GAMMA IRRADIATION; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; RADIATION EXPOSURE; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALIA;

EID: 0037124322     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdf307     Document Type: Article

References (53)

1. Enhanced phosphorylation of p53 by ATM in response to DNA damage
2. ATM selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways
3. DNA-dependent protein kinase-independent activation of p53 in response to DNA damage
4. Activation of the ATM kinase by ionising radiation and phosphorylation of p53
5. Phosphorylation of Ser-20 mediates stablisation of human p53 in response to DNA damage
6. A retrovirus expressing the 12S adenovirus E1A gene product can immortalise epithelial cells from a broad range of rat tissues
7. Transcriptional activation by p53 correlates with suppression of growth but not transformation
8. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B
9. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
10. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
11. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway
12. Absence of a Ku-like DNA end binding activity in the xrs double-strand DNA repair-deficient mutant
13. The complexity of p53 modulation: Emerging patterns from divergent signals
14. Structure of the p53 tumour suppressor bound to the ankyrin and SH3 domains of 53BP2
15. The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen
16. Chromatin condensation is not associated with apoptosis
17. Mediation of c-myc induced apoptosis by p53
18. Requirement for Atm in ionising radiation-induced cell death in the developing central nervous system
19. Small peptides activate the latent sequence-specific DNA binding function of p53
20. Two cellular proteins that bind to wild-type p53 but not mutant p53
21. CS: A T-cell tumour suppressor encoded at the mouse scid locus
22. The p53 reponse to DNA damage in vivo is independent of DNA-dependent protein kinase
23. DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage
24. A mammalian cell cycle checkpoint pathway utilising p53 and GADD45 is defective in ataxia-telangiectasia
25. Catalytic subunit of DNA-dependent protein kinase: Impact on lymphocyte development and tumourigenesis
26. p53 and its 14kDa C-terminal domain recognise primary DNA damage in the form of insertion/deletion mismatches
27. Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53 and the human Ku autoantigen
28. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53
29. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line
30. Atm is dispensable for p53 apoptosis and tumor suppression triggered by cell cycle dysfunction
31. Stabilisation of the p53 tumour suppressor is induced by adenovirus-5 E1A and accompanies apoptosis
32. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
33. Differential induction of transcriptionally active p53 following UV or ionising radiation: Defects in chromosome instability syndromes?
34. In vivo ubiquitination and proteosome-mediated degradation of p53
35. DNA-dependent protein kinase is activated by nicks and larger single-stranded gaps
36. Regulation of the p53 tumour suppressor protein
37. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis
38. Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase
39. Deregulated expresion of E2F-1 induces S-phase entry and leads to apoptosis
40. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
41. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization
42. DNA damage induces phosphorylation of the amino terminus of p53
43. p53-dependent apoptosis suppresses tumour growth and progression in vivo
44. Ku80 product of the Xrcc5 gene and its role in DNA repair and V(D)J recombination
45. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2
46. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity
47. waf1/cip1
48. The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest
49. Threonine 68 of Chk2 is phosphorylated at sites of DNA strand breaks
50. Atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity
51. DNA dependent protein kinase acts upstream of p53 in response to DNA damage
52. p53 and E2F-1 cooperate to mediate apoptosis
53. Dual roles of ATM in the cellular response to radiation and in cell growth control